Gibofsky A, Winchester R, Hansen J, Patarroyo M, Dupont B, Paget S, Lahita R, Halper J, Fotino M, Yunis E, Kunkel H G
Arthritis Rheum. 1978 Jun;21(5 Suppl):S134-8. doi: 10.1002/art.1780210920.
The Ia alloantigens as measures of different alleles of loci in the major histocompatibility complex were determined in patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). The Ia specificities of reagents used were defined by their pattern of reaction with lymphoblastoid lines derived from normal donors homozygous for HLA-D determinants. The reagent specificities included those associated with a single Dw type as well as those reacting with a single specificity shared by several Dw types. Patients with RA had a marked elevation in the frequency of alloantigens detected by reagent sera that recognize various determinants shared by cell lines from HLA-Dw4, Dw7, or Dw10 individuals (Ia 4-7-10). The frequency of mixed lymphocyte culture alleles Dw4 and Dw10 was found to be increased; however this elevation did not approach the higher frequency for the serologically determined antigens of the Ia 4-7-10 group. In contrast, patients with SLE had an increased frequency of reactions with the reagent alloantisera defined by reactions with either HLA-Dw2 or Dw3 positive cell lines. The data suggest that immunogenetic factors are relevant to both groups of patients, but that these are entirely distinct for each disease.
在系统性红斑狼疮(SLE)或类风湿关节炎(RA)患者中,确定了Ia同种异体抗原作为主要组织相容性复合体中不同基因座等位基因的衡量指标。所用试剂的Ia特异性是通过它们与源自HLA - D决定簇纯合正常供体的淋巴母细胞系的反应模式来定义的。试剂特异性包括与单一Dw类型相关的那些以及与几种Dw类型共有的单一特异性反应的那些。类风湿关节炎患者中,识别来自HLA - Dw4、Dw7或Dw10个体的细胞系共有的各种决定簇的试剂血清所检测到的同种异体抗原频率显著升高(Ia 4 - 7 - 10)。发现混合淋巴细胞培养等位基因Dw4和Dw10的频率增加;然而,这种升高并未达到Ia 4 - 7 - 10组血清学确定抗原的较高频率。相比之下,系统性红斑狼疮患者与由HLA - Dw2或Dw3阳性细胞系反应定义的试剂同种抗血清反应的频率增加。数据表明免疫遗传因素与两组患者都相关,但每种疾病的这些因素完全不同。